¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Annals of Hepatology

Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2024

4.4

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2024

9.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2024

1.011

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2024

1.057

View more metrics

Hide

Last published articles

Brief report

Fenofibrate in managing cholestatic pruritus in paediatric patients

Jesús Quintero-Bernabeu, Javier Juamperez-Goñi, Cristina Padrós-Fornieles, Mauricio Larrarte-King, Simone Mameli, Lis Vidal-Valdivia, Susana Clemente-Bautista, Aurora Fernández-Polo, ... Maria Mercadal-Hally

Ann Hepatol. 2026;31:102132

Full text access

Share

Original article

Drug-induced liver injury: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database (2004–2024)

Dongxuan Li, Duan Wang, Guili Huang, Qinglong Liu, Yalan Wang, Rui Zhang, Songqing Liu, Qian Du

Ann Hepatol. 2026;31:102156

Full text access

Share

Original article

Prevalence of cirrhotic cardiomyopathy in liver transplant candidates: Impact on pre- and post-transplant mortality

Ignacio Roca, Cecilia Morales, Mariela De Santos, Nicolas Dominguez, Luciana Meza, Manuel Barbero, Lucia Navarro, Omar Galdame, ... Graciela Reyes

Ann Hepatol. 2026;31:102141

Full text access

Share

Letters to the editor

Toward standardization and translation of stem cell therapy in liver failure

Parth Aphale, Himanshu Shekhar, Shashank Dokania

Ann Hepatol. 2026;31:102164

Full text access

Share

More last published articles

Latest issue

Issue

Vol. 31. Issue 1. (In progress)

Vol. 31. Issue 1. (In progress)

(January - June 2026)

This issue is in progress but contains articles that are final and fully citable.

Opinions

Beyond the association: towards an integrated hepato–renal approach

Juanita Pérez-Escobar, Ricardo Ivan Velazquez-Silva, Paulina Carpinteyro-Espin, José Carlos Gasca-Aldama

Ann Hepatol. 2026;31:102155

Full text access

Share

Original Articles

Impact of neohepatic albumin-bilirubin scores on renal outcomes following living donor liver transplantation: a propensity score analysis

Hye-Won Jeong, Hye-Mee Kwon, Sung-Hoon Kim, Seong-Mi Yang, In-Gu Jun, Jun-Gol Song, Gyu-Sam Hwang

Ann Hepatol. 2026;31:102111

Full text access

Share

Prognosis of hepatocellular carcinoma in the French overseas territories and comparison with a tertiary center in mainland France

Alolia Aboikoni, Manon Allaire, Dominique Louvel, Marthe Alogo A. Nwatsok, Paul Ngock Dime, Ala Ouni, Larissa Tangan, Magaly Zappa, ... Moana Gelu-Simeon

Ann Hepatol. 2026;31:102120

Full text access

Share

Diagnosis of metabolic dysfunction-associated steatotic liver disease by triglyceride glucose-body mass index: A systematic review and meta-analysis

Kexin Du, Yafang Huang, Yanhui Yu, Jianrong Guo, Jianmei Feng, Feng Jiang

Ann Hepatol. 2026;31:102122

Full text access

Share

View latest issue View all issues

Ahead of print

Ahead of print are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Clostridium butyricum reduces the incidence of overt hepatic encephalopathy in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt (TIPS)

Xiaotong Xu, Tong Zhu, Changyou Jing, Kunlei Zhu, Qinghua Meng, Jianjun Li

Full text access

Pre-proof. Available online 16 January 2026

Share

Left-sided portal hypertension: Local venous congestion without ascites

Seoung Hoon Kim

Full text access

Pre-proof. Available online 16 January 2026

Share

Screening and management for portal hypertension in hepatocellular carcinoma: A nationwide survey in China

Xueyan Li, Huiyu Chen, Qingqing Zhang, Shaotong Wang, Youping Wang, Yixuan Chen, Jun Song, Mingkai Chen

Full text access

Pre-proof. Available online 16 January 2026

Share

View all Ahead of print

Editorial Board

Norberto C. Chávez-Tapia

Norberto C. Chávez-Tapia, MD, PhD

Fundación Clínica Médica Sur, Mexico City, Mexico

View editorial board

All issues

portada-January - June

January - June

Volume 31 . Issue. 1

In progress

portada-July - December

July - December

Volume 30 . Issue. 2

portada-January - June

January - June

Volume 30 . Issue. 1

portada-November - December

November - December

Volume 29 . Issue. 6

View all issues

Supplements

portada-Vol. 30. Issue S2.

September

Volume 30. Issue. S2

Abstracts of the 2025 Annual Meeting of the ALEH

portada-Vol. 30. Issue S1.

April

Volume 30. Issue. S1

Abstracts Asociación Mexicana de Hepatología (AMH) 2024

portada-Vol. 29. Issue S3.

December

Volume 29. Issue. S3

Abstracts of the 2024 Annual Meeting of the ALEH

portada-Vol. 29. Issue S2.

February

Volume 29. Issue. S2

Abstracts Asociación Mexicana del Hígado (AMH) 2023

View all supplements

Instructions for authors

Publish in Annals of Hepatology

Most often read

Position Paper

Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group

Luis Antonio Diaz, Juan Pablo Arab, Francisco Idalsoaga, Javiera Perelli, Javier Vega, Melisa Dirchwolf, Javiera Carreño, Bárbara Samith, Cynthia Valério, Rodrigo Oliveira Moreira, Mónica Acevedo, Javier Brahm, Nelia Hernández, Adrian Gadano, Claudia P. Oliveira, Marco Arrese, Graciela Castro-Narro, Mario G. Pessoa

10.1016/j.aohep.2025.101903

Ann Hepatol. 2025;30:

This article has been read 38.042 times

View all Most Often read articles

Article options

Tools